Raymond James Sticks to Its Buy Rating for NGM Biopharmaceuticals (NGM)
alphanewsstream
2021-05-07 21:00
Raymond James Sticks to Its Buy Rating for NGM Biopharmaceuticals (NGM)
In a report released today, Steven Seedhouse from Raymond James maintained a Buy rating on NGM Biopharmaceuticals (NGM), with a price target of ...
The post Raymond James Sticks to Its Buy Rating for NGM Biopharmaceuticals (NGM) appeared first on Smarter Analyst.
In a report released today, Steven ...

https://www.smarteranalyst.com/new-blurbs/raymond-james-sticks-to-its-buy-rating-for-ngm-biopharmaceuticals-ngm-2/

#SmarterAnalyst
Piilota kommentit Kommentit (0)

Sinun täytyy kirjautua sisään ennen kuin voit kommentoida.